Liquid Nitrogen

NHS LPP is assessing the feasibility of establishing a framework agreement or Dynamic Market for the provision of liquid nitrogen used in clinical and laboratory settings, including dermatology, oncology, fertility, pathology, histopathology, and biobanking. Final structure and progression will depend on assessed market needs. This procurement will be subject to subsequent approvals from the internal LPP Executive, NHSE Commercial Efficiencies Optimisation Programme and Cabinet Office Spend Controls